| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-2143(97)90004-4 |
| P698 | PubMed publication ID | 9142046 |
| P50 | author | Didier Raoult | Q915676 |
| P2093 | author name string | Weiller PJ | |
| Soler C | |||
| Bernard D | |||
| Gerolami V | |||
| Christides C | |||
| Sanmarco M | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus | Q33363443 | ||
| Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 | ||
| Antiphospholipid antibodies and recurrent pregnancy loss | Q33416855 | ||
| 'Primary', 'secondary' and other variants of the antiphospholipid syndrome | Q33490042 | ||
| Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies | Q33566956 | ||
| The antiphospholipid syndrome: a syndrome in evolution | Q33567393 | ||
| Antiphospholipid syndrome within systemic lupus erythematosus | Q40558532 | ||
| Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
| Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies | Q43464737 | ||
| Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis | Q48394757 | ||
| Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid | Q67991471 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen | Q68042865 | ||
| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
| Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease | Q68091809 | ||
| Cofactor dependent and cofactor independent anticardiolipin antibodies | Q70148532 | ||
| Surface modification and evaluation of some commonly used catheter materials. I. Surface properties | Q71666525 | ||
| Detection of anti-bovine ?2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome | Q72002718 | ||
| Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? | Q72345769 | ||
| Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis | Q72585164 | ||
| P433 | issue | 5 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| antibody | Q79460 | ||
| P304 | page(s) | 499-506 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies | |
| P478 | volume | 129 |
| Q73262237 | Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism |
| Q72989787 | Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome |
| Q61892603 | Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease |
| Q44898311 | Anti-cardiolipin antibodies in sera from patients with periodontitis |
| Q45013121 | Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propyluracil or methimazole |
| Q33328447 | Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards |
| Q36222874 | Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. |
| Q28362586 | Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections |
| Q44286410 | Correlation between beta 2-glycoprotein antibodies and antiphospholipid antibodies in patients with reproductive failure |
| Q40376795 | Coxiella burnetii as a possible cause of autoimmune liver disease: a case report |
| Q46413307 | Diagnostic performance of anti-beta2 glycoprotein I and anticardiolipin assays for clinical manifestations of the antiphospholipid syndrome |
| Q33330002 | Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome? |
| Q37967416 | Drug-induced lupus anticoagulants and antiphospholipid antibodies |
| Q33333394 | Monocyte tissue factor induction by activation of beta 2-glycoprotein-I-specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies |
| Q35399567 | Optimising testing for phospholipid antibodies |
| Q43677862 | Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE). |
| Q47739764 | Prevalence of beta2-glycoprotein I antibody in patients with liver cirrhosis: relationship with beta2-glycoprotein I plasma levels and thrombosis |
| Q42378680 | Rational Laboratory Diagnostics of Antiphospholipid Antibodies: Anti-Cardiolipin, Anti-β2-Glycoprotein I, Anti-Prothrombin and Anti-Annexin V Antibodies |
| Q79858058 | Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome |
| Q33443797 | Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study |
| Q73829352 | [Pulmonary embolism in a patient with Q fever. Are the anticardiolipin antibodies the origin?] |
| Q52081764 | beta2-Glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss. |
Search more.